Mike Recher
SDHA gain-of-function engages inflammatory mitochondrial retrograde signaling via KEAP1-Nrf2
Burgener A, Dimeloe S, Lötscher J, Sauder U, Ebnöther M, Burger B, Heijnen I, Martínez-Cano S, Cantoni N, Brücker R, Kahlert C, Sancho D, Jones R, Navarini A, Recher M, Epple R, Grählert J, Müller-Durovic B, Bantug G, Meyer B, Higgins R, Ghosh A, Bignucolo O, Ma E, Loeliger J, Unterstab G, Geigges M, Steiner R, Enamorado M, Ivanek R, Hunziker D, Schmidt A, Hess C. SDHA gain-of-function engages inflammatory mitochondrial retrograde signaling via KEAP1-Nrf2. Nat Immunol 2019; 20:1311-1321.
16.09.2019SDHA gain-of-function engages inflammatory mitochondrial retrograde signaling via KEAP1-Nrf2
16.09.2019Nat Immunol 2019; 20:1311-1321
Burgener Anne-Valérie, Dimeloe Sarah, Lötscher Jonas, Sauder Ursula, Ebnöther Monika, Burger Bettina, Heijnen Ingmar, Martínez-Cano Sarai, Cantoni Nathan, Brücker Rolf, Kahlert Christian, Sancho David, Jones Russell G, Navarini Alexander, Recher Mike, Epple Raja, Grählert Jasmin, Müller-Durovic Bojana, Bantug Glenn R, Meyer Benedikt J, Higgins Rebecca, Ghosh Adhideb, Bignucolo Olivier, Ma Eric H, Loeliger Jordan, Unterstab Gunhild, Geigges Marco, Steiner Rebekah, Enamorado Michel, Ivanek Robert, Hunziker Danielle, Schmidt Alexander, Hess Christoph
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer
Berner F, Hartmann F, Cheng H, Hönger G, Recher M, Goldman J, Cozzio A, Früh M, Neefjes J, Driessen C, Ludewig B, Hegazy A, Jochum W, Speiser D, Zippelius A, Läubli H, Bomze D, Diem S, Ali O, Fässler M, Ring S, Niederer R, Ackermann C, Baumgaertner P, Pikor N, Cruz C, van de Veen W, Akdis M, Nikolaev S, Flatz L. Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer. JAMA Oncol 2019; 5:1043-1047.
01.07.2019Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer
01.07.2019JAMA Oncol 2019; 5:1043-1047
Berner Fiamma, Hartmann Fabienne, Cheng Hung-Wei, Hönger Gideon, Recher Mike, Goldman Jonathan, Cozzio Antonio, Früh Martin, Neefjes Jacques, Driessen Christoph, Ludewig Burkhard, Hegazy Ahmed N, Jochum Wolfram, Speiser Daniel E, Zippelius Alfred, Läubli Heinz, Bomze David, Diem Stefan, Ali Omar Hasan, Fässler Mirjam, Ring Sandra, Niederer Rebekka, Ackermann Christoph J, Baumgaertner Petra, Pikor Natalia, Cruz Cristina Gil, van de Veen Willem, Akdis Mübeccel, Nikolaev Sergey, Flatz Lukas
Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment
Diem S, Risch M, Recher M, Risch L, Dummer R, Levesque M, Mangana J, Hillmann D, Niederer R, Berner F, Ali O, Bomze D, Fässler M, Flatz L. Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment. J Immunother 2019; 42:89-93.
01.04.2019Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment
01.04.2019J Immunother 2019; 42:89-93
Diem Stefan, Risch Martin, Recher Mike, Risch Lorenz, Dummer Reinhard, Levesque Mitchell P, Mangana Joanna, Hillmann Dorothea, Niederer Rebekka, Berner Fiamma, Ali Omar Hasan, Bomze David, Fässler Mirjam, Flatz Lukas
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
Fässler M, Jörger M, Recher M, Risch L, Güsewell S, Risch M, Speiser D, Ludewig B, Levesque M, Dummer R, Siano M, Krolik M, Diem S, Mangana J, Hasan Ali O, Berner F, Bomze D, Ring S, Niederer R, Gil Cruz C, Pérez Shibayama C, Flatz L. Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients. J Immunother Cancer 2019; 7:50.
20.02.2019Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
20.02.2019J Immunother Cancer 2019; 7:50
Fässler Mirjam, Jörger Markus, Recher Mike, Risch Lorenz, Güsewell Sabine, Risch Martin, Speiser Daniel E, Ludewig Burkhard, Levesque Mitchell P, Dummer Reinhard, Siano Marco, Krolik Michal, Diem Stefan, Mangana Joanna, Hasan Ali Omar, Berner Fiamma, Bomze David, Ring Sandra, Niederer Rebekka, Gil Cruz Cristina, Pérez Shibayama Christian Ivan, Flatz Lukas
Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients
Quteineh L, Mohacsi P, Dufour J, Soccal P, Kutalik Z, Marques-Vidal P, Vollenweider P, Recher M, Hess C, Pascual M, Eap C, Steiger J, Van Delden C, Wójtowicz A, Bochud P, Crettol S, Vandenberghe F, Venetz J, Manuel O, Golshayan D, Lehmann R, Mueller N, Binet F, Swiss Transplant Cohort Study. Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients. Am J Transplant 2018; 19:238-246.
13.07.2018Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients
13.07.2018Am J Transplant 2018; 19:238-246
Quteineh Lina, Mohacsi Paul, Dufour Jean-François, Soccal Paola M, Kutalik Zoltán, Marques-Vidal Pedro, Vollenweider Peter, Recher Mike, Hess Christoph, Pascual Manuel, Eap Chin B, Steiger Jürg, Van Delden Christian, Wójtowicz Agnieszka, Bochud Pierre-Yves, Crettol Severine, Vandenberghe Frederik, Venetz Jean-Pierre, Manuel Oriol, Golshayan Déla, Lehmann Roger, Mueller Nicolas J, Binet Françoise-Isabelle, Swiss Transplant Cohort Study
Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis
Navarini A, Bignucolo O, Meyer B, Meienberg F, Mehling M, Jeker L, Heijnen I, Daikeler T, Gebbers J, Grimbacher B, Sansom D, Jeker R, Hess C, Jauch A, Kistner A, Bigler M, Hruz P, Berger C, Hou T, Schwab C, Gabrysch A, Higgins R, Frede N, Padberg S, Kämpe O, Burgener A, Marquardsen F, Baldin F, Recher M. Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis. J Allergy Clin Immunol 2016; 139:1043-1046.e5.
28.11.2016Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis
28.11.2016J Allergy Clin Immunol 2016; 139:1043-1046.e5
Navarini Alexander A, Bignucolo Olivier, Meyer Benedikt, Meienberg Fabian, Mehling Matthias, Jeker Lukas T, Heijnen Ingmar, Daikeler Thomas D, Gebbers Jan-Olaf, Grimbacher Bodo, Sansom David M, Jeker Raphael, Hess Christoph, Jauch Annaise, Kistner Anne, Bigler Marc, Hruz Petr, Berger Christoph T, Hou Tie Zheng, Schwab Charlotte, Gabrysch Annemarie, Higgins Rebecca, Frede Natalie, Padberg Sgier, Kämpe Olle, Burgener Anne-Valérie, Marquardsen Florian, Baldin Fabian, Recher Mike
Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice
Lang P, Zinkernagel R, Ohashi P, Häussinger D, Harris N, Hengartner H, Ludewig B, Kalinke U, Van Rooijen N, Cervantes-Barragan L, Kulawik A, Meryk A, Krings C, Gailus N, Borkens S, Scheu S, Honke N, Recher M, Lang K. Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology 2010; 52:25-32.
01.03.2010Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice
01.03.2010Hepatology 2010; 52:25-32
Lang Philipp A, Zinkernagel Rolf M, Ohashi Pamela S, Häussinger Dieter, Harris Nicola, Hengartner Hans, Ludewig Burkhard, Kalinke Ulrich, Van Rooijen Nico, Cervantes-Barragan Luisa, Kulawik Andreas, Meryk Andreas, Krings Caroline, Gailus Nicole, Borkens Stephanie, Scheu Stefanie, Honke Nadine, Recher Mike, Lang Karl S
Hematopoietic cell-derived interferon controls viral replication and virus-induced disease
Lang P, Ohashi P, Ludewig B, Honda K, Bergthaler A, Flatz L, Pellegrini M, Recher M, Navarini A, Verschoor A, Cervantes-Barragan L, Lang K. Hematopoietic cell-derived interferon controls viral replication and virus-induced disease. Blood 2009; 113:1045-52.
29.01.2009Hematopoietic cell-derived interferon controls viral replication and virus-induced disease
29.01.2009Blood 2009; 113:1045-52
Lang Philipp A, Ohashi Pamela S, Ludewig Burkhard, Honda Kenya, Bergthaler Andreas, Flatz Lukas, Pellegrini Marc, Recher Mike, Navarini Alexander A, Verschoor Admar, Cervantes-Barragan Luisa, Lang Karl S
Aggravation of viral hepatitis by platelet-derived serotonin
Lang P, Bader M, Graf R, Clavien P, Hegazy A, Löhning M, Harris N, Ohashi P, Hengartner H, Zinkernagel R, Odermatt B, Merkler D, Contaldo C, Georgiev P, El-Badry A, Recher M, Kurrer M, Cervantes-Barragan L, Ludewig B, Calzascia T, Bolinger B, Lang K. Aggravation of viral hepatitis by platelet-derived serotonin. Nature medicine 2008; 14:756-61.
01.07.2008Aggravation of viral hepatitis by platelet-derived serotonin
01.07.2008Nature medicine 2008; 14:756-61
Lang Philipp A, Bader Michael, Graf Rolf, Clavien Pierre-Alain, Hegazy Ahmed N, Löhning Max, Harris Nicola L, Ohashi Pamela S, Hengartner Hans, Zinkernagel Rolf M, Odermatt Bernhard, Merkler Doron, Contaldo Claudio, Georgiev Panco, El-Badry Ashraf Mohammad, Recher Mike, Kurrer Michael, Cervantes-Barragan Luisa, Ludewig Burkhard, Calzascia Thomas, Bolinger Beatrice, Lang Karl S
Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses
Navarini A, Hengartner H, Odermatt B, Landmann R, Bille J, Flatz L, Bergthaler A, Meury S, Georgiev P, Lang K, Recher M, Zinkernagel R. Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc Natl Acad Sci USA 2006; 103:15535-9.
09.10.2006Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses
09.10.2006Proc Natl Acad Sci USA 2006; 103:15535-9
Navarini Alexander A, Hengartner Hans, Odermatt Bernhard, Landmann Regine, Bille Jacques, Flatz Lukas, Bergthaler Andreas, Meury Susanne, Georgiev Panco, Lang Karl S, Recher Mike, Zinkernagel Rolf M